The Arkansas attorney general has filed a lawsuit accusing several drugmakers and pharmacy benefit managers of conspiring to set prices for insulin, the second time a state has taken such a step as a growing number of Americans struggle to afford the life-savings diabetes treatment.
The lawsuit alleged the companies “unfairly and deceptively” drove up the cost of insulin, making the medication unaffordable for many of the “hundreds of thousands” of state residents with diabetes and costing the state government “millions of dollars in overcharges.”